RESEARCH TRIANGLE PARK, N.C. – February 13, 2008 – Quintiles Transnational Corp. today announced that its central laboratory in India has been certified by the College of American Pathologists (CAP).
The central lab in Mumbai began supporting clinical trials in the first quarter of 2007. The facility has seen steady growth and has been adding services and analytical capabilities to a growing test menu.
“CAP certification validates our commitment to providing high-quality central laboratory services that fulfill rigorous regulatory requirements worldwide,” said Tom Wollman, Senior Vice President, Quintiles Global Central Laboratories. “With the certification of the India laboratory, Quintiles Central Laboratory Services now has the largest wholly owned CAP-accredited laboratory network in the world. This tightly controlled network with CAP-certified laboratories in the US, Europe, South Africa, China, India and Singapore allows us to support global and regional trials in almost every country in the world. Because our customers are looking for the quality, flexibility and speed that come from running multi-regional global trials, we are well-positioned to meet this demand.”
CAP certification follows a site inspection. The accreditation is intended to improve patient safety by advancing the quality of pathology and laboratory services through education, setting standards and ensuring laboratories meet or exceed regulatory requirements.
In addition to laboratory testing, the Mumbai lab provides project management and logistical support, study specific laboratory kits for sites, local investigator support and samples management, storage and processing using consistent global methods. All laboratory data collected is globally harmonized and included in the Quintiles Laboratory Information Management System (QLIMS) and the protocol-specific database.
About Quintiles LaboratoriesQuintiles Laboratories owns a CAP-certified network of clinically harmonized facilities in the U.S., Europe, South Africa, India, China and Singapore, and has a tightly controlled network of sub-contractor laboratories in Argentina and Brazil managed by Quintiles employees located in each of the sub-contractor facilities.
Quintiles Transnational Corp. is powering the next generation of healthcare by providing a broad range of professional services in drug development, financial partnering and commercialization for the pharmaceutical, biotechnology and healthcare industries. With more than 19,000 employees and offices in more than 50 countries, it is focused on providing customer-centric solutions that are the gold standard of the industry. For more information, please visit the company’s Web site at www.quintiles.com.